Keywords
How to Cite
Abstract
Ushbu maqolada prenatal diagnostika va genetik skriningning zamonaviy tibbiyotdagi o‘rni, irsiy va xromosomal kasalliklarni erta aniqlashdagi samaradorligi hamda reproduktiv salomatlikni yaxshilashdagi ahamiyati tahlil qilindi. Tadqiqotda invaziv va noinvaziv prenatal diagnostika usullarining afzalliklari, ularning aniqlik darajasi, xavflilik ko‘rsatkichlari hamda klinik qo‘llanish sohalari ilmiy jihatdan yoritildi. Shuningdek, ultratovush tekshiruvi, bioximik skrining va NIPT kabi molekulyar-genetik testlarning xromosomal anomaliyalar (Daun sindromi, Edvards, Patau)ni aniqlashdagi diagnostik qiymati tahlil qilindi. Olingan maʼlumotlar prenatal skriningning tug‘ma kasalliklarning oldini olishda, homila rivojlanishini kompleks baholashda va perinatal xavflarni kamaytirishda muhim ahamiyatga ega ekanini ko‘rsatadi.
References
ACOG Practice Bulletin No. 226. Screening for Fetal Chromosomal Abnormalities. American College of Obstetricians and Gynecologists, 2020.
2. Norton, M.E., Jacobsson, B., Swamy, G.K., et al. Cell-free DNA Analysis for Noninvasive Examination of Trisomy. New England Journal of Medicine, 2015.
3. Wald, N.J., Hackshaw, A.K. Combining Ultrasound and Biochemical Markers in First-Trimester Screening for Down Syndrome. Prenatal Diagnosis, 1997.
4. Benn, P., Borell, A., Chiu, R., et al. Noninvasive Prenatal Testing: Clinical Performance and Counseling Considerations. Genetics in Medicine, 2013.
5. Nicolaides, K.H. First Trimester Screening for Chromosomal Abnormalities. Fetal Diagnosis and Therapy, 2004.
6. Driscoll, D.A., Gross, S. Prenatal Screening for Aneuploidy. Obstetrics & Gynecology, 2009.
7. Malone, F.D., D’Alton, M.E. First-Trimester Screening for Aneuploidy. Clinical Obstetrics and Gynecology, 2005.
8. Wapner, R.J., et al. Chromosomal Microarray vs. Standard Karyotyping for Prenatal Diagnosis. New England Journal of Medicine, 2012.
This work is licensed under a Creative Commons Attribution 4.0 International License.